SAT0151 TIME TO INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE FRENCH COHORT ESPOIR
Published: May 27, 2019
Abstract
Background:
Access to biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) of early rheumatoid arthritis (RA) patients is highly variable across countries and may depend on patient characteristics, disease expression, physicians behaviors as well as care organization in the patient region of living.Objectives:
1) To assess the time to initiation of bDMARDs in the French cohort ESPOIR, and 2) To assess the factors...Paper Details
Title
SAT0151 TIME TO INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE FRENCH COHORT ESPOIR
Published Date
May 27, 2019
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History